Dolby Laboratories, Inc.
DLB
$75.34
$0.360.48%
NYSE
| 03/28/2025 | 12/27/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.52% | 17.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.52% | 17.12% | |||
| Cost of Revenue | -12.11% | 19.94% | |||
| Gross Profit | 5.53% | 16.77% | |||
| SG&A Expenses | -2.70% | 4.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.26% | 4.68% | |||
| Operating Income | 31.58% | 88.83% | |||
| Income Before Tax | 39.74% | 44.06% | |||
| Income Tax Expenses | 55.85% | 1,971.54% | |||
| Earnings from Continuing Operations | 35.49% | 15.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -74.60% | 16.22% | |||
| Net Income | 35.34% | 15.80% | |||
| EBIT | 31.58% | 88.83% | |||
| EBITDA | 24.24% | 61.78% | |||
| EPS Basic | 34.34% | 15.52% | |||
| Normalized Basic EPS | 35.03% | 56.77% | |||
| EPS Diluted | 34.29% | 16.14% | |||
| Normalized Diluted EPS | 35.60% | 56.23% | |||
| Average Basic Shares Outstanding | 0.75% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.33% | 0.57% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.25% | -0.05% | |||